1. Home
  2. SEER vs PGP Comparison

SEER vs PGP Comparison

Compare SEER & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

N/A

Current Price

$1.56

Market Cap

113.0M

Sector

Health Care

ML Signal

N/A

Logo Pimco Global StocksPlus & Income Fund of Beneficial Interest

PGP

Pimco Global StocksPlus & Income Fund of Beneficial Interest

N/A

Current Price

$8.17

Market Cap

93.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SEER
PGP
Founded
2017
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
113.0M
93.8M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
SEER
PGP
Price
$1.56
$8.17
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
★ 142.8K
43.9K
Earning Date
11-10-2026
01-01-0001
Dividend Yield
N/A
★ 10.84%
EPS Growth
★ 9.40
N/A
EPS
N/A
★ N/A
Revenue
★ $16,578,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.50
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 16.99
N/A
52 Week Low
$1.55
$7.95
52 Week High
$2.38
$9.41

Technical Indicators

Market Signals
Indicator
SEER
PGP
Relative Strength Index (RSI) 27.98 46.61
Support Level N/A $8.07
Resistance Level $1.85 $8.87
Average True Range (ATR) 0.12 0.14
MACD -0.02 0.02
Stochastic Oscillator 5.45 37.66

Price Performance

Historical Comparison
SEER
PGP

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest

PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, as well as long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.

Share on Social Networks: